Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4168129)

Published in PLoS One on September 17, 2014

Authors

Jessica M Snyder1, Piper M Treuting1, Lee Nagy2, Cathy Yam2, Jaehun Yi2, Alicia Brasfield2, Lisa Phuong Anh Nguyen2, Adeline M Hajjar2

Author Affiliations

1: Department of Comparative Medicine, University of Washington, Seattle, Washington, United States of America; Comparative Pathology Program, University of Washington, Seattle, Washington, United States of America.
2: Department of Comparative Medicine, University of Washington, Seattle, Washington, United States of America.

Articles citing this

Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA. EMBO Rep (2015) 0.83

TRAF3: a novel tumor suppressor gene in macrophages. Macrophage (Houst) (2015) 0.79

Articles cited by this

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12

High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol (2003) 7.47

Oncogenically active MYD88 mutations in human lymphoma. Nature (2010) 7.34

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity (2006) 6.00

Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol (2006) 6.00

Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science (2006) 5.30

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med (2005) 4.85

Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity (2007) 4.07

A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A (2006) 3.70

Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov (2010) 3.35

Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol (2007) 3.17

Xist RNA is a potent suppressor of hematologic cancer in mice. Cell (2013) 2.93

Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med (2005) 2.89

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest (2006) 2.17

TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol (2010) 2.09

Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle (2008) 1.98

Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol (2007) 1.69

RNA recognition by human TLR8 can lead to autoimmune inflammation. J Exp Med (2013) 1.64

TLR8 deficiency leads to autoimmunity in mice. J Clin Invest (2010) 1.46

The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol (1993) 1.43

Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity (2013) 1.40

New generation humanized mice for virus research: comparative aspects and future prospects. Virology (2013) 1.38

Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum (2007) 1.37

Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur J Immunol (2008) 1.36

Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (2008) 1.33

Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc Natl Acad Sci U S A (2012) 1.28

Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood (2006) 1.26

Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. Eur J Immunol (2012) 1.24

Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol (2008) 1.23

Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine (2010) 1.15

Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog (2012) 1.13

TLR8: the forgotten relative revindicated. Cell Mol Immunol (2012) 1.12

Cutting edge: Type I IFN drives emergency myelopoiesis and peripheral myeloid expansion during chronic TLR7 signaling. J Immunol (2013) 1.08

Monocytosis in the BXSB model for systemic lupus erythematosus. J Exp Med (1984) 1.07

Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J Immunol (2013) 1.06

Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma. Lab Invest (2010) 1.06

Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett (2014) 1.03

Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proc Natl Acad Sci U S A (2013) 1.03

Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. J Immunol (2011) 0.94

Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med (2013) 0.94

Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice. Toxicol Pathol (2004) 0.92

TLR7 and TLR9 trigger distinct neuroinflammatory responses in the CNS. Am J Pathol (2011) 0.91

The toll of too much TLR7. Immunity (2007) 0.91

Periocular inflammation in mice with experimental systemic lupus erythematosus. A new experimental blepharitis and its modulation. J Immunol (1995) 0.89

Mouse models of systemic lupus erythematosus reveal a complex pathogenesis. Vet Pathol (2010) 0.89

Expression of mononuclear phagocyte antigens in histiocytic sarcoma of mice. Vet Pathol (1993) 0.83

Genetic signature of histiocytic sarcoma revealed by a sleeping beauty transposon genetic screen in mice. PLoS One (2014) 0.83

Circulating microparticles in neuropsychiatric systemic lupus erythematosus. Int J Rheum Dis (2013) 0.80

The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis. J Neuroimmunol (2012) 0.79

Rodent immunohistochemistry: pitfalls and troubleshooting. Vet Pathol (2013) 0.78